Many of the Pulmonary Center faculty and trainees are practicing physicians in the the Section of Pulmonary, Allergy, Sleep, and Critical Care Medicine within the Department of Medicine. Explore the many conditions we treat and our clinical care locations.
In this interview, Nicholas Bosch, MD goes into depth about his recent study and subsequent publication. Nicholas Bosch MD, MSc Assistant Professor, Pulmonary, Allergy, Sleep & Critical Care Medicine Bosch NA, Teja B, Law AC, Pang B, Jafarzadeh SR, Walkey AJ. Comparative Effectiveness of Fludrocortisone and Hydrocortisone vs Hydrocortisone Alone Among Patients With […]
The Pulmonary Center is happy to announce Mary Lou Beermann as the winner of the 2023 Kayla Bell Pulmonary Center Citizenship Award! Mary Lou Beermann Lab Manager, BU Center for Regenerative Medicine (CReM) Mary Lou was selected as this year's recipient of the award for their exceptional contributions to our research community. Their kindness, […]
Several of our current or recent trainees have received exciting news. Congratulations to the following for these fellowship or faculty transition awards: "Microbial Dysbiosis and Epithelial Dysfunction in Vitamin A-deficient Lungs" F31 Predoctoral Fellowship, NIH Date of Award: 2/20/2023 Kiloni Quiles-Franco PhD Candidate - Molecular and Translational Medicine Pulmonary Center and Section of […]
Our Pulmonary Center community is heartbroken by the loss of Jerry Brody, who passed away peacefully on January 22, 2023, at his home in Boston while surrounded by family, after a brave battle against Alzheimer's disease. He was 88 years old. Jerry meant so much to us here at BU and in the Pulmonary Center. […]
This project developed to address limitations in our understanding of the genetic factors that predispose a subset of individuals exposed to environmental injury to develop COPD, a major contributor to morbidity and mortality worldwide. While genome-wide association studies (GWAS) have now identified 82 variants across the genome as significantly associated with risk of developing COPD, […]
In 2022, the major challenge in cystic fibrosis is developing treatments for individuals who do not respond to highly effective modulator therapy. These individuals have mutations that lead to no residual CFTR protein. In vitro models have a proven track record in developing effective treatments for CF patients however access to cells from these high […]
In June, we were delighted to learn that our new R01 entitled Biology of Lymphangiogenesis in the Adult Lung was funded. This work builds upon exciting data generated by Senegal Carty (PiBS graduate student) and Erin Crossey MD, PhD (pulmonary fellow; Figure 1) demonstrating that robust lymphangiogenesis (Figure 2) and changes in lymphatic cell phenotype […]
Joseph Kaserman, MD Assistant Professor My award is from the Alpha-1 Foundation and is a 2-year Research Grant award from the foundation. The Title of the proposal is “Mechanisms of Hepatic Heterogeneity and ATF6 Mediated Metabolic Dysfunction in AATD.” In this proposal we are investigating mechanisms that could be contributing to the increased risk of […]